BackWest Pharmaceutical Services Overview

West Pharmaceutical Services Long Term Debt

Track West Pharmaceutical Services's long-term debt ($290M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$291.20M

Peer average

Loading

West Pharmaceutical Services Long Term Debt History

Loading

West Pharmaceutical Services vs. peers: Long Term Debt Comparison

Loading

West Pharmaceutical Services Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

West Pharmaceutical Services (WST) FAQ

As of the most recent data (June 2026), WST shows a long-term debt of $290M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, WST's long-term debt is now $290M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether West Pharmaceutical Services is outperforming or lagging.

Tracking WST's long-term debt over time shows whether West Pharmaceutical Services is scaling, shrinking, or reshaping that part of the business. The current reading is $290M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has West Pharmaceutical Services's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $290M) with ownership activity and broader fundamentals.

West Pharmaceutical Services's long-term debt is $290M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.